Last reviewed · How we verify

Conventional oral morphine

Children's Hospital of Fudan University · FDA-approved active Small molecule ✓ Verified May 2026

Conventional oral morphine is a Opioid analgesic Small molecule drug developed by Children's Hospital of Fudan University. It is currently FDA-approved for Moderate to severe acute pain, Moderate to severe chronic pain, Cancer pain. Also known as: Conventional group.

Morphine binds to opioid receptors in the central and peripheral nervous system to reduce pain perception and provide analgesia.

Conventional oral morphine is used to treat various conditions, including inflammation, acute and chronic pain, and is also studied in the context of gastric-bypass surgery. Its mechanism of action is not explicitly stated in the provided facts, but it is likely related to its analgesic properties, which are commonly associated with morphine's interaction with opioid receptors.

At a glance

Generic nameConventional oral morphine
Also known asConventional group
SponsorChildren's Hospital of Fudan University
Drug classOpioid analgesic
TargetMu-opioid receptor (μ-OR)
ModalitySmall molecule
Therapeutic areaPain management
PhaseFDA-approved

Mechanism of action

Morphine is a mu-opioid receptor agonist that crosses the blood-brain barrier and acts on opioid receptors in the brain, spinal cord, and peripheral tissues. This binding modulates pain signal transmission and produces analgesic, sedative, and euphoric effects. The conventional oral formulation provides immediate-release analgesia suitable for acute and chronic pain management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Conventional oral morphine

What is Conventional oral morphine?

Conventional oral morphine is a Opioid analgesic drug developed by Children's Hospital of Fudan University, indicated for Moderate to severe acute pain, Moderate to severe chronic pain, Cancer pain.

How does Conventional oral morphine work?

Morphine binds to opioid receptors in the central and peripheral nervous system to reduce pain perception and provide analgesia.

What is Conventional oral morphine used for?

Conventional oral morphine is indicated for Moderate to severe acute pain, Moderate to severe chronic pain, Cancer pain.

Who makes Conventional oral morphine?

Conventional oral morphine is developed and marketed by Children's Hospital of Fudan University (see full Children's Hospital of Fudan University pipeline at /company/children-s-hospital-of-fudan-university).

Is Conventional oral morphine also known as anything else?

Conventional oral morphine is also known as Conventional group.

What drug class is Conventional oral morphine in?

Conventional oral morphine belongs to the Opioid analgesic class. See all Opioid analgesic drugs at /class/opioid-analgesic.

What development phase is Conventional oral morphine in?

Conventional oral morphine is FDA-approved (marketed).

What are the side effects of Conventional oral morphine?

Common side effects of Conventional oral morphine include Constipation, Nausea, Drowsiness, Dizziness, Vomiting, Respiratory depression.

What does Conventional oral morphine target?

Conventional oral morphine targets Mu-opioid receptor (μ-OR) and is a Opioid analgesic.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing